Purpose

Are you undergoing treatment for a blood cancer diagnosis and experiencing poor sleep?


Researchers at the Mays Cancer Center are seeking US-based adults diagnosed with blood cancer and experiencing sleep disturbance to participate in a 20-week remote study testing a digital wellness intervention. Participants in this study will be assigned to use one of two digital wellness apps 10 minutes per day over 8-weeks to determine if it can help improve sleep, immune function, and other psychological and emotional outcomes.


This study is completely remote (there are no in-person visits with the research team) and patients from across the USA are invited.


Participation involves:


Participants who qualify and are enrolled in the study will be compensated at regular intervals, up to $100 total.

Category

IRB Number
20220567HU
NCT Number
-
Open to Enrollment
Yes
Sponsor
-



Study Contact

Principal Investigator
Jennifer Huberty

Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu

Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu

Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu

Courtney Nichols
(210) 450-1794
nicholsc2@uthscsa.edu

Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu

Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu

Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu

Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu

Jillian Johnson
+1 (814) 424-5601
johnsonj27@uthscsa.edu



Eligibility

Eligible Ages
18
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

    You may qualify for the study if you:

    • Are over 18 and reside in the USA
    • Have a blood cancer diagnosis and are currently receiving treatment
    • Experience sleep disturbance, such as difficulty falling asleep, staying asleep, or poor quality of sleep
    • Own a smartphone

    Are willing to complete the study procedures

Exclusion Criteria

    Other Exclusion Criteria:

    • Not residing in the USA
    • Non-English speaking
    • Not in active treatment or not on stable treatment
    • Diagnosed or at high risk for sleep apnea

    Regular use of sleep aids on 3 or more nights per week


Study Design

Arm Groups